Skip to main content
Zyvex Zyvex Pharmaceuticals
Photo 1 of 1 Click to zoom

Product photograph of the current pack. Each physical unit carries the same blue-teal ZX label artwork, a batch code and a scratch-off verification panel.

Injectable Steroids

Masteron 200

Drostanolone Enanthate

Compound
Drostanolone Enanthate
Brand
Masteron
Manufacturer
Zyvex Pharmaceuticals
Presentation
10 ml
Strength
200 mg/ml
Route
Injection
Storage
15–25 °C, protected from light, do not freeze

Batch analysis

Independent batch results for Masteron 200 are not yet published. They will be added here once testing is complete.

Product information

About Masteron 200

200 mg/mL · 10 mL · Zyvex Pharmaceuticals

Masteron 200 from Zyvex Pharmaceuticals contains drostanolone enanthate at 200 mg/mL and comes in a 10 mL presentation.

This prospect summarises composition, clinical considerations and handling. It supports professional review and does not replace an individual prescription or verified instructions for the exact preparation.

Basic Identification & Composition

Product Name & Active Ingredient

Masteron 200 is the product name used by Zyvex Pharmaceuticals. The ingredient discussed in the following sections is drostanolone enanthate, classified as a anabolic androgenic steroid.

Qualitative & Quantitative Composition

Property Details
Product name Masteron 200
Manufacturer Zyvex Pharmaceuticals
Active ingredient Drostanolone Enanthate
Strength 200 mg/mL
Package 10 mL
Drug class Anabolic androgenic steroid
Chemical formula C27H44O3
Presentation Injectable preparation; route as verified on the medicinal label

Dosage Form

An injectable preparation supplied by concentration and pack volume. The vehicle and whether the preparation is a solution or suspension affect handling. Administration must follow the exact medicinal label and appropriate sterile technique; do not infer the route from concentration alone.

Clinical Particulars

Masteron 200 uses

Masteron 200 from Zyvex Pharmaceuticals contains drostanolone enanthate. Drostanolone enanthate is a different ester from the drostanolone propionate used in historical breast-cancer research. That history does not establish an equivalent medical use or dosing schedule for the enanthate preparation.

People use drostanolone preparations to pursue muscular definition and physique changes. A reported aim should not be presented as proof that this particular ester improves wellbeing or sporting performance.

No reliable human medical schedule for this exact ester was established from the reviewed sources. Propionate oncology doses cannot be transferred to enanthate, and the vial strength does not determine an injection interval. Cardiovascular and hormonal risks remain relevant even when users perceive an androgen as mild.

Dosage and Administration

A reliable routine human dosing regimen cannot be established from the available clinical evidence. The product strength must not be converted into a self-treatment schedule. Human use requires an appropriately supervised clinical or research setting with a defined protocol. A regimen used for an animal preparation or another ester must not be transferred to this injectable product.

Contraindications

A complete human contraindication profile cannot be assumed for this preparation. Avoid use with hypersensitivity, during pregnancy or breastfeeding, or in children. Significant cardiovascular, liver, kidney, prostate or endocrine disease requires specialist assessment. These precautions do not establish suitability in people without those conditions.

Warnings and Precautions

Human evidence for this particular ester and preparation is limited. General androgen risks include gonadal suppression, adverse lipid changes, increased haematocrit and virilisation. Injection also introduces risks from contamination and local injury. Short-term tolerance does not establish long-term safety.

Risks and Interactions

Drug & Food Interactions

Formal human interaction data for this preparation are limited. Androgen-class interactions with anticoagulants, glucose-lowering medicines and other hormones remain relevant considerations. A clinician should review all medicines and supplements; combining agents does not reliably prevent adverse effects.

Pregnancy and Lactation

Avoid during pregnancy because androgen exposure can affect fetal sexual development. Breastfeeding requires specialist advice. Suppression of gonadotropins can reduce sperm production and fertility; recovery is variable.

Side Effects and Adverse Reactions

Possible androgen-class effects include acne, hair changes, altered libido, fluid retention, mood effects, menstrual disturbance and impaired fertility. Injection-site pain or infection may occur. Reliable ingredient-specific human frequencies are not established, and class risks should not be mistaken for a complete adverse-event profile.

Overdose Protocol

For a suspected overdose, contact a poison-information service or urgent medical care and provide the product, amount, time and other substances taken. Collapse, seizures or breathing difficulty require emergency help. Do not induce vomiting or attempt an antidote at home. Clinical treatment depends on symptoms and the substances involved.

Scientific & Technical Data

Pharmacodynamics

Drostanolone Enanthate is an ester of drostanolone. Ester cleavage releases the parent androgen, which acts at androgen receptors. Chemical similarity to other anabolic steroids does not establish equivalent clinical effects or safety.

Pharmacokinetics

The ester and formulation influence release of drostanolone from an injection depot. Metabolism and excretion of the parent compound follow release. Human pharmacokinetic data are insufficient to assign a dependable dosing interval or half-life to this catalogue preparation.

Storage and Handling

Keep the finished injectable preparation in its original container and outer packaging, protected from light and extremes of temperature. Use only documented temperature and expiry conditions for that formulation. Do not assume that refrigeration, freezing or warming is appropriate. A pharmacist should assess any temperature excursion or visible change. Keep injectable medicines in their original packaging, protected from light and excessive heat and out of children's reach. Follow the finished medicine's temperature limits and expiry date. Check the container and solution before use. A vial's size does not establish whether it can be reused: follow its single-dose or multidose instructions and the specified discard time after opening. Dispose of needles in a sharps container.

Product request

Enquire about Masteron 200

Send a pricing, sample or distribution request. The product (Masteron 200 (200 mg/ml · 10 ml)) is included automatically, and our team replies within one business day.